Particle.news

Download on the App Store

Study Links Early Pregnancy Anaemia to 47% Higher Risk of Congenital Heart Disease

New UK research highlights the potential of iron supplementation before and during pregnancy to reduce congenital heart disease cases in newborns.

Image

Overview

  • A study published in BJOG confirms that anaemia in the first 100 days of pregnancy increases the odds of congenital heart disease (CHD) in newborns by 47%.
  • Researchers analysed anonymised GP records from over 16,500 mothers in the UK between 1998 and 2020, identifying a significant correlation between early maternal anaemia and CHD.
  • Congenital heart disease, affecting 13 babies daily in the UK, is a leading cause of infant mortality, with maternal anaemia estimated to account for 5% of cases.
  • Experts are now investigating whether widespread iron supplementation before and during pregnancy could serve as a preventive measure against CHD.
  • The findings underscore the importance of early screening and nutritional interventions, as nearly a quarter of UK pregnant women and over a third globally experience anaemia.